Carbonic anhydrase inhibitors derivatives
AssigneeNicox S.A.
InventorsFrancesca Benedini, Stefano Biondi, Ennio Ongini
Life of this patent
Estimating the term…
Abstract
Nitroderivatives of dorzolamide and brinzolamide having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma, ocular hypertension, age-related macular degeneration, diabetic macular edema, diabetic retinopathy, hypertensive retinopathy and retinal vasculopathies.
Claims20
A method for treating eye disorders in a patient in need thereof comprising administering a therapeutically effective amount of a carbonic anhydrase inhibitor able to release nitric oxide.
A compound of general formula (I) or a pharmaceutically acceptable salt or stereoisomer thereof.
- R—(X—Y—ONO2)m (I)
- wherein:
- m is an integer equal to 1 or 2;
- R is:
- wherein
- R1 is —CH3 or —(CH2)3—OCH3;
- R2 is H or a group —(X—Y—ONO2),
- R′ is H or a group —(X—Y—ONO2);
- with the proviso that at least one of R2 or R′ is a —(X—Y—ONO2) group;
- A is a carbon or nitrogen atom;
- X is —CO—, —COO—;
- Y is a bivalent radical having the following meaning:
- (a)
- straight or branched Cl-C20 alkylene,
- straight or branched C1-C20 alkylene substituted with one or more of the substituents selected from the group consisting of:
- halogen atoms, hydroxy, —ONO2 or T, wherein T is —OC(O)(C,-C10 alkyl)-ONO2 or —O(C1-Clo alkyl)-ONO2;
- cycloalkylene with 5 to 7 carbon atoms into cycloalkylene ring, the ring being optionally substituted with side chains T1, wherein T1 is straight or branched C1-C1,3 alkyl;
- wherein n is an integer from 0 to 20, and n1 is an integer from 1 to 20;
- wherein
- X1=—OCO— or —COO—;
- Z is —(CH2)n1— or the bivalent radical defined above under b);
- n1 is as defined above and
- n2 is an integer from 0 to 2 and R3 is H or —CH3;
- wherein:
- Y1 is —CH2—CH2—CH2)n2a or —CH═CH—(CH2)n2a wherein n2a is from 0 to 2;
- Z, n1, n2, R3 and X1 are as defined above;
- wherein:
- n1 is an integer from 1 to 20 and R3 is H or —CH3,
- R0 is H or —COCH3;
- with the proviso that when Y is selected from the bivalent radicals mentioned under b)-f), then the terminal —ONO2 group is bound to —(CH2)n1,
- wherein X2 is -0- or —S—, n3 is an integer from 1 to 6, R3 is H or —CH3;
- wherein:
- n4 is an integer from 0 to 10;
- n5 is an integer from 1 to 10;
- R4, R5, R6, R7 are the same or different, and are H or straight or branched C1-C4 alkyl;
- wherein the —ONO2 group is linked to
- wherein n5 is as defined above;
- Y2 is an heterocyclic saturated, unsaturated or aromatic 5 or 6 members ring, containing one or more heteroatoms selected from nitrogen, oxygen, sulfur,
- and is selected from the group consisting of:
Dependencies are inferred from the claim text.